BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Whiteley EL, Tejeda GS, Baillie GS, Brandon NJ. PDE10A mutations help to unwrap the neurobiology of hyperkinetic disorders. Cell Signal 2019;60:31-8. [PMID: 30951862 DOI: 10.1016/j.cellsig.2019.04.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Ooms M, Bormans G. PET Imaging of Phosphodiesterases in Brain. In: Dierckx RA, Otte A, de Vries EF, van Waarde A, Lammertsma AA, editors. PET and SPECT of Neurobiological Systems. Cham: Springer International Publishing; 2021. pp. 851-77. [DOI: 10.1007/978-3-030-53176-8_23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Tejeda GS, Whiteley EL, Deeb TZ, Bürli RW, Moss SJ, Sheridan E, Brandon NJ, Baillie GS. Chorea-related mutations in PDE10A result in aberrant compartmentalization and functionality of the enzyme. Proc Natl Acad Sci U S A 2020;117:677-88. [PMID: 31871190 DOI: 10.1073/pnas.1916398117] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
3 Blokland A, Heckman P, Vanmierlo T, Schreiber R, Paes D, Prickaerts J. Phosphodiesterase Type 4 Inhibition in CNS Diseases. Trends in Pharmacological Sciences 2019;40:971-85. [DOI: 10.1016/j.tips.2019.10.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
4 Creus-Muncunill J, Ehrlich ME. Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models. Neurotherapeutics 2019;16:957-78. [PMID: 31529216 DOI: 10.1007/s13311-019-00782-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]